SG/CALL/ABBOTT LABORATORIES/115/0.1/20.09.24 Stock

Warrant

DE000SQ3G804

Delayed Deutsche Boerse AG 05:48:58 2024-07-16 am EDT
0.096 EUR -4.00% Intraday chart for SG/CALL/ABBOTT LABORATORIES/115/0.1/20.09.24
Current month-9.09%
1 month-28.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.096 -4.00%
24-07-15 0.1 -16.67%
24-07-12 0.12 -7.69%
24-07-11 0.13 +18.18%
24-07-10 0.11 +22.22%

Delayed Quote Deutsche Boerse AG

Last update July 16, 2024 at 05:48 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ3G80
ISINDE000SQ3G804
Date issued 2022-10-27
Strike 115 $
Maturity 2024-09-20 (67 Days)
Parity 10 : 1
Emission price 1.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.7
Lowest since issue 0.083
Spread 0.024
Spread %20.00%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
103 USD
Average target price
124.8 USD
Spread / Average Target
+21.20%
Consensus